A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis

By sjmartinez • March 4, 2025

Mozas P, Ould Ammar R, Chartier L, Nastoupil L, Bachy E, Bezsera SM, Barnes J, Bijou F, Goy A, Zerazhi H, Cartron G, Ojeda-Uribe M, Choquet S, Joly B, Cheminant M, Martín García-Sancho A, Eradat H, Gressin R, Abrisqueta P, Parcelier A, Rodríguez Salazar MJ, Bonnet C, Johnson NA, López-Guillermo A, Morschhauser F. A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis. Br J Haematol. 2025 Mar 3. doi: 10.1111/bjh.20038. Epub ahead of print. PMID: 40031898.

Tags: chemoimmunotherapy, follicular lymphoma, Hematology/Oncology, lymphocyte‐to‐monocyte ratio, prognosis, Publications, rituximab–lenalidomide, survival

Susan Ettner, PhD and Dennis J. Slamon, MD, PhD Elected to the National Academy of Medicine

The UCLA Department of Medicine (DoM) is pleased to congratulate Susan Ettner, PhD and Dennis Slamon, MD, PhD, on their election to the National Academy[...]

B-Lymphoblastic Leukemia Presenting as Bilateral Ovarian Masses in a 20-Year-Old Woman

Cai J, Sin D, Varda M, Lewis L, Yeh J. B-Lymphoblastic Leukemia Presenting as Bilateral Ovarian Masses in a 20-Year-Old Woman. Clin Case Rep. 2026[...]

Putting the Patient at the Center of Patient-Centered Care

Rocque G, Nipp R, Sedrak MS. Putting the Patient at the Center of Patient-Centered Care. JCO Oncol Pract. 2026 Oct 16:OP2600798. doi: 10.1200/OP-26-00798. Epub ahead[...]